Literature DB >> 320661

Control of influenza and poliomyelitis with killed virus vaccines.

J Salk, D Salk.   

Abstract

The requirements for inducing immunity against an infectious disease are outlined, and the application of these requirements to the development of effective vaccines (vaccinology) is discussed. Influenza and poliomyelitis are examined from this viewpoint, and data are presented that demonstrate the effectiveness of killed virus vaccines against these diseases. A comparison between live and killed poliovirus vaccines suggests the desirability of returning to the use of a killed virus vaccine for the eradication of polio. The natural history of influenza and experience with vaccination suggest that influenza might be brought under effective control by routine immunization in childhood with a polyvalent killed virus vaccine potentiated by an immunologic adjuvant.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 320661     DOI: 10.1126/science.320661

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

Review 1.  The development and use of vaccine adjuvants.

Authors:  Robert Edelman
Journal:  Mol Biotechnol       Date:  2002-06       Impact factor: 2.695

2.  Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice.

Authors:  S E Coffin; C A Moser; S Cohen; H F Clark; P A Offit
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Vaccination with cell immunoglobulin mucin-1 antibodies and inactivated influenza enhances vaccine-specific lymphocyte proliferation, interferon-gamma production and cross-strain reactivity.

Authors:  W Soo Hoo; E R Jensen; A Saadat; D Nieto; R B Moss; D J Carlo; T Moll
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

4.  Immunity and protection, the unfolding of a tale.

Authors:  Maurizio Zanetti
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 5.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  Polio vaccines and polioviruses.

Authors:  J Salk
Journal:  Br Med J       Date:  1977-09-17

7.  Epidemiological events surrounding a paralytic case of poliomyelitis in Sweden.

Authors:  M Böttiger; P Mellin; V Romanus; H Söderström; T Wesslen; G von Zeipel
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

8.  Improved genotyping vaccine and wild-type poliovirus strains by restriction fragment length polymorphism analysis: clinical diagnostic implications.

Authors:  A Georgopoulou; P Markoulatos; N Spyrou; N C Vamvakopoulos
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

9.  Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction.

Authors:  M F Bachmann; H Hengartner; R M Zinkernagel
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

10.  Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.

Authors:  Tihamer Orban; Klara Farkas; Heyam Jalahej; Janos Kis; Andras Treszl; Ben Falk; Helena Reijonen; Joseph Wolfsdorf; Alyne Ricker; Jeffrey B Matthews; Nadio Tchao; Peter Sayre; Pete Bianchine
Journal:  J Autoimmun       Date:  2010-06       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.